Sachin Goel

Medical Director, Structural Heart Interventions, Houston Methodist, #MitraClip #TAVR #LAAO #TMVR, #Triclip, #TTVR, Cleveland Clinic alum, opinions my own

[Nadeen N. Faza, M.D. @NadeenFaza]

Amazing energy at our annual #CVBootCamp26 ! Thrilled to welcome 50 new cardiology fellows from across the U.S., along with fellows from the UK & the Dominican Republic. Looking forward to a few days of learning, collaboration & building lasting connections. 🫀 #CardioTwitter #MedEd #ACCFIT

[WilliamZoghbi @WilliamZoghbi]

Proud of and so thankful to our amazing team and Institution @HMethodistCV for the national recognition of our stellar service to patients❤️
@ACCinTouch @ASE360 @American_Heart @MyASNC @escardio @SCMR @NYTHealth @AUBMC_Official @SCAI @worldheartfed

[Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 @DrMarthaGulati]

Congratulations to @HMethodistCV for ranking #10 on @usnews for Heart Care in America & Being Number 1 in Texas!
🙏🏽 @WilliamZoghbi @AlanLumsdenMD for their leadership 🫀👏🏽👏🏽👏🏽👏🏽

https://t.co/HALqTf3rRf

[Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 @DrMarthaGulati]

Celebration of breaking the Top 10 today @HMethodistCV #teamwork
@valeriaduarteMD @NadeenFaza @khurramn1 @SachinGoelMD @kershawpatel @CindyMMartinMD

[Sachin Goel @SachinGoelMD]

@kardiologykazi @rblument1 @CircOutcomes @NancyatHeart @American_Heart @SmithBIDMC Congratulations @kardiologykazi !

[Sachin Goel @SachinGoelMD]

@PWesslyMD @JACCJournals @NadeenFaza @iamritu @CASivaram1 @DermotPhelanMD @WilliamZoghbi @HMethodistCV @HMHCardioFellow @HCAHoustonCVD Thanks for sharing @PWesslyMD , it was a pleasure working on this editorial with you.

[Priscilla Wessly @PWesslyMD]

🎯 Residual MR or a higher gradient? The answer is becoming clearer.
Our editorial in @JACCJournals discusses an emerging paradigm in M-TEER:
🫀 Residual MR matters more than a modest transmitral gradient. Aim for MR ≤1+.
Grateful to @JACCJournals and @SachinGoelMD for the opportunity to write this editorial, and congratulations to @AkhilNarangMD and the entire CLASP IID team on this important work @ACCinTouch @ASE360
📖 https://t.co/jWnuEuaU9y

[Houston Methodist Cardiovascular Fellowships @HMHCardioFellow]

A new journey begins!
Our first-year Cardiovascular Disease Fellows are officially kicking off their first day at Houston Methodist, proudly representing in their HMH black jackets. We are excited to welcome this outstanding group, Welcome to the team! #HMHCardio #HMHFellows

[Sachin Goel @SachinGoelMD]

Honored to present our late‑breaking CoreValve/Evolut TAVR durability data @crfheart #NYValves2026: <3% reintervention, <6% bioprosthetic valve failure at 8 yrs, SVD main failure mechanism. Proud of our fellows’ contributions and grateful for the chance to share and learn.

[venu menon @venumenon10]

14 years ago, I had the privilege of taking over as PD of the CCF cards program from Brian. As he plans retirement, the program and our graduates owe him a debt of gratitude for creating the foundations on which our outstanding training program is built. @tavrkapadia @CCFcards

[Dr. Gilbert Tang @GilbertTangMD]

FINALLY HERE #JACCINT @JACCJournals in time for simultaneous publication at #NYValves2026! Our international group of #TAVR #TAVI experts convened to produce this Heart & Valve Collaboratory (H&VC) 2-part BEST PRACTICE document on REDO-TAVR, from concepts to planning to procedural execution to troubleshooting / complication mitigation. Hope you'll find the KEY PRACTICAL TAKEAWAYS useful in your daily practice encountering the growing volume of failed #TAVR. We look forward to producing an annual update as we publish more data and evidence on this topic, since no doubt the best practices will evolve with time.

Thank you to ALL THE CO-AUTHORS who collaborated on this monumental effort!

Part 1: Short-in-Short, Short-in-Tall
https://t.co/ho9A97XE3i
Full PDF here
https://t.co/bvcBrSGvBD
Supplement:
https://t.co/cLtsFMDbGw

Part 2: Tall-in-Short, Tall-in-Tall
https://t.co/GEWhbrGKmK
Full PDF here
https://t.co/thyAE3AEFD
Supplement:
https://t.co/Lzxwa1d78p

[Alpesh Shah M.D. @AlpeshShahMD]

One of the most thought provoking and transformative grand rounds. His work and concepts transcends the field of Interventional cardiology. Thank you @rwyeh Absolute honor to have him visit us @HMethodistCV @WilliamZoghbi @khurramn1 @SachinGoelMD

[Sachin Goel @SachinGoelMD]

@timir_paul @ascenstthomas @UTHSCMedicine @OchsnerCardio @Hragy @mmamas1973 @SandeepNathanMD Congratulations Timir!

[Sachin Goel @SachinGoelMD]

@MahsimaShabani @WilliamZoghbi @HMHCardioFellow Congratulations Mahsima!

[Sachin Goel @SachinGoelMD]

@WilliamZoghbi @MReardon19 @SLittleMD @NadeenFaza @MohakGuptaMD @KrityaMangesh @mdatkinsmd @frdv_md @Joe_Aoun_ @mderdem3 @HanadBashirMD @HMHCardioFellow @khurramn1 @almallahmo @DipanJShah @Sadeer_AlKindi @DrMarthaGulati @KharsaChloe Karl Abou Zeid, Marcel Szekely, Davis Leaphart

[Sachin Goel @SachinGoelMD]

Thrilled to be presenting late-breaking data on 8-year TAVR durability and reintervention with Evolut Valve #NYValves2026 on 6/24. Honored to be part of a powerhouse session on long-term TAVR outcomes. Grateful to my co-investigators @HMethodistMD https://t.co/icjtd5j0PK

[WilliamZoghbi @WilliamZoghbi]

A special evening celebrating our 18 graduating Core & Advanced Cardiology Fellows! Thank you for amazing years and congratulations. You make us all so proud.👏🏼👏🏼
@ACCinTouch @HMethodistCV @ASE360 @SCMR @Heart_SCCT @escardio @AHAScience

[Sachin Goel @SachinGoelMD]

@TWilsonMD @SriniTummala @farkomd @_backtable @JayMathewsMD @TomVargheseJr @drAliyor @cingolani_oscar @Obisht @IntervnCardio If I had to make a choice, hospital cath lab; however to be honest, I have never worked in OBL, hence not completely fair to comment.

[Sachin Goel @SachinGoelMD]

@SabhaBhatti @ahakeem143 @AJamilTajik @ppsengupta1 @mmamas1973 @Hragy @dr_cilingiroglu @nicvd_karachi @RWJUH @AKUGlobal @Drroxmehran Congrats @ahakeem143 . Wish I could have been at #EuroPCR. Looking forward to reading your findings.

[Robert W. Yeh @rwyeh]

Excited to share two papers that we hope will give readers a framework for reading and conducting observational studies that are intended to compare treatments.

First, a systematic approarch for comparing cardiovascular devices using observational data.

https://t.co/jL427WbA8m